Affordable Access

deepdyve-link
Publisher Website

Pilot randomized psychosocial trial of a screening intervention in pediatric oncology.

Authors
  • Barrera, Maru1
  • Desjardins, Leandra2
  • Prasad, Soni1
  • Shama, Wendy3
  • Alexander, Sarah4
  • Szatmari, Peter5
  • Hancock, Kelly1
  • 1 Division of Hematology/Oncology, Department of Psychology, SickKids Hospital, Toronto, Ontario, Canada. , (Canada)
  • 2 Cancer Axis, Research Centre, Sainte-Justine University Health Centre, Montreal, Quebec, Canada. , (Canada)
  • 3 Division of Social Work, SickKids Hospital, Toronto, Ontario, Canada. , (Canada)
  • 4 Division of Hematology/Oncology, SickKids Hospital, Toronto, Ontario, Canada. , (Canada)
  • 5 Cundill Centre for Child and Youth Depression, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. , (Canada)
Type
Published Article
Journal
Psycho-Oncology
Publisher
Wiley (John Wiley & Sons)
Publication Date
May 01, 2022
Volume
31
Issue
5
Pages
735–744
Identifiers
DOI: 10.1002/pon.5857
PMID: 34813129
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Psychosocial screening is a standard of care in pediatric oncology, but there is limited information about how to intervene after screening. This pilot trial aimed to determine feasibility of the novel Enhanced Psychosocial Screening Intervention (EPSI) and explore its preliminary efficacy outcomes. We examined rates of recruitment, retention, intervention acceptability, and monthly distress screening completion, as well as exploratory efficacy outcomes (Patient-Reported Outcomes Measurement Information System: depression, anxiety and fatigue; distress thermometer, pain and sleep). Parallel-group randomized pilot trial: Caregiver-youth (10-17 years at enrollment, newly diagnosed with cancer) dyads were randomly allocated to either EPSI or standard care with 1:1 ratio allocation. EPSI consists of having a Psychosocial Navigator who shares screening results conducted near diagnosis and monthly for one year with treating teams and families, and provides recommendations tailored to screening results. Enrollment rate was 54% (38 dyads); retention was 90% and acceptability 86% (caregivers) and 76% (youth). Exploratory symptoms of depression, anxiety, distress and fatigue outcomes consistently improved mainly for caregivers. Results suggest EPSI is feasible and acceptable and exploratory mental and physical efficacy outcomes are promising for use in a future confirmatory multisite efficacy trial. © 2021 John Wiley & Sons Ltd.

Report this publication

Statistics

Seen <100 times